Chat with us, powered by LiveChat

Past

51st Organic Process Research and Development

The 51st OPRD Conference was held in San Deigo! The event provided scientific content alongside the renowned networking receptions. Lhasa joined others in this fantastic location to hear cutting-edge scientific content and the latest scientific updates from industry alongside renowned networking receptions.¬† We had the chance to connect with other like-minded chemists and benefit from …

51st Organic Process Research and Development Read More »

Leachables sensitisation assessment framework in collaboration with ELSIE

This enlightening event brought together esteemed members of the Extractables and Leachables Safety Information Exchange (ELSIE) consortium for a captivating discussion on the sensitisation potential of extractables and leachables (E&Ls). Featured presenters and ELSIE consortium members included: Patricia Parris, Global Risk Assessment Services Toxicologist at Pfizer Geraldine Whelan, Regulatory Toxicologist at GSK Martyn Chilton, Principal …

Leachables sensitisation assessment framework in collaboration with ELSIE Read More »

Performing ICH M7 risk assessment for process impurities and degradation products (in Spanish)

Performing ICH M7 risk assessment for process impurities and degradation products was targeted towards Latin America and carried out in Spanish. In this event, we explored how our software solution, Zeneth, can help you to identify potential degradation impurities in your drug development workflow. We also demonstrated how to classify potentially mutagenic impurities through our …

Performing ICH M7 risk assessment for process impurities and degradation products (in Spanish) Read More »

Streamlining your drug development workflow using purge calculations (in Japanese)

Join us for our webinar, Streamlining your drug development workflow using purge calculations. This webinar was hosted in Japanese and contained pre-recorded videos with Japanese subtitles. We were delighted to have Senior Principal Scientist Andy Teasdale, presenting in this webinar. Andy is currently the chair of AstraZeneca’s Impurity advisory Board, and has developed a wealth …

Streamlining your drug development workflow using purge calculations (in Japanese) Read More »

3rd annual genotoxic impurities summit: Nitrosamines & beyond 2023

The safety, quality and clinical results of drug substances and drug products may be disrupted by the formation of nitrosamines along with other mutagenic impurities. The comprehensive development and production of innovative medicines now inevitably involves estimating impurity profiles as well as managing and monitoring them. To meet the demands of ever-increasing regulatory standards and …

3rd annual genotoxic impurities summit: Nitrosamines & beyond 2023 Read More »

American College of Toxicology (ACT) Annual Meeting

We attended the American College of toxicology (ACT) 2023, in Orlando Florida! ACT is a global community of professional scientists representing the pharmaceutical and biotech industries, regulatory agencies, contract research organizations, academia, and consulting firms. The 44th Annual Meeting will include a wide-ranging scientific program and educational courses, with distinguished plenary speakers, the popular Poster …

American College of Toxicology (ACT) Annual Meeting Read More »

52nd Annual Meeting of the Japanese Environmental Mutagen and Genome Society (JEMS)

We were thrilled to participate in the annual conference of the Japanese Environmental Mutagen and Genome Society (JEMS). Since its inception in 1972, the society has been dedicated to advancing fundamental research on mutagens that have substantial implications for public health. The exciting event included various symposia, poster presentations, and research presentations by experts on …

52nd Annual Meeting of the Japanese Environmental Mutagen and Genome Society (JEMS) Read More »